|
US2929812A
|
|
Physiologically active alkaloids protoveratrine a and protoveratrine b
|
|
US2909461A
|
|
Process for combating trichuris infection of domestic animals
|
|
GB845147A
|
|
Modified edible fat products containing essential fatty acids
|
|
DE1044362B
|
|
Process for the development of attenuated canine infectious hepatitis viruses
|
|
GB878704A
|
|
Propagation of attenuated infectious canine hepatitis virus in trypsinized tissue cultures of pig kidney and the preparation of a vaccine therefrom
|
|
US2941925A
|
|
Bovine rhinotracheitis vaccine and methods of production
|
|
GB846755A
|
|
Bovine rhinotracheitis vaccine and methods of production
|
|
DE1027367B
|
|
Process for the production of a mixed vaccine for dogs
|
|
US2890959A
|
|
Emulsified oleaginous spread containing essential fatty acids and process of making same
|
|
GB840670A
|
|
Process for preparing a vaccine comprising a combination of modified live virus distemper vaccine and modified live virus infectious hepatitis vaccine
|
|
US2831864A
|
|
1-p-alkoxyphenyl-1-alkyl-3-piperidino-1-propenes
|
|
DE1024678B
|
|
Process for the manufacture of vaccines for immunizing dogs against canine hepatitis
|
|
GB839876A
|
|
A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus
|
|
US2868689A
|
|
Pharmaceutical preparations containing dyclonine hydrochloride and chlorobutanol
|
|
GB829426A
|
|
Corrective shampoos containing cadmium sulfide
|
|
DE1084438B
|
|
Shampoos
|
|
US2934473A
|
|
Bovine rhinotracheitis vaccine and methods of production
|
|
US2915436A
|
|
Process for the attenuation of infectious canine hepatitis virus and a vaccine prepared therefrom
|
|
IE21608L
|
|
Therapeutic composition
|
|
ES218023A1
|
|
A procedure to prepare a composition to combat trichuris infections in mammals (Machine-translation by Google Translate, not legally binding)
|
